Harrow, Inc.

HROW ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 5, 2026 8-K
8-K Sep 4, 2026 8-K
144 Aug 21, 2026
4 Aug 17, 2026 4
10-Q Aug 10, 2026 10-Q
8-K Aug 10, 2026 8-K
8-K Aug 6, 2026 8-K
SCHEDULE 13G/A Jul 31, 2026
4 Jun 22, 2026 4
4 Jun 22, 2026 4
4 Jun 22, 2026 4
8-K Jun 22, 2026 8-K
8-K Jun 3, 2026 8-K
4 May 19, 2026 4
4 May 19, 2026 4
4 May 18, 2026 4
4 May 15, 2026 4
4 May 15, 2026 4
10-Q May 11, 2026 10-Q
SCHEDULE 13G/A May 11, 2026
8-K May 11, 2026 8-K
DEFA14A Apr 24, 2026 DEFA14A
DEF 14A Apr 24, 2026 DEF 14A
8-K Mar 27, 2026 8-K
SCHEDULE 13G/A Mar 27, 2026
← Newer Page 1 of 35 · 867 filings Older →